| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,884 vol |
48,696 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-34,000
-20,000 vol $1.70 each |
422,700 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-3,238 vol |
0 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$13,503
+7,943 vol $1.70 each |
20,934 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-3,238 vol |
0 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-79,430
-47,000 vol $1.69 each |
377,700 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$19,952
+11,806 vol $1.69 each |
46,812 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,577 vol |
991,946 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Units Restricted Share Units
57 - Exercise of rights
|
-13,102 vol |
0 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-17,951.18
-7,943 vol $2.26 each |
12,991 | |
| Filed 2018-04-02 Tx date 2018-03-28 |
$COM
Cardiome Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,625 vol |
12,991 | |
| Filed 2018-03-27 Tx date 2018-03-23 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$311,250
+125,000 vol $2.49 each |
375,000 | |
| Filed 2018-03-27 Tx date 2018-03-26 |
$COM
Cardiome Pharma Corp. |
Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,844
+10,000 vol $1.98 each |
30,000 | |
| Filed 2018-03-27 Tx date 2018-03-23 |
$COM
Cardiome Pharma Corp. |
Renz, Justin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$286,500
+150,000 vol $1.91 each |
425,000 | |
| Filed 2018-03-27 Tx date 2018-03-26 |
$COM
Cardiome Pharma Corp. |
Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$330,000
+200,000 vol $1.65 each |
985,369 | |
| Filed 2018-03-27 Tx date 2018-03-26 |
$COM
Cardiome Pharma Corp. |
Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-330,000
-200,000 vol $1.65 each |
1,333,000 | |
| Filed 2018-03-27 Tx date 2018-03-23 |
$COM
Cardiome Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$238,750
+125,000 vol $1.91 each |
424,700 | |
| Filed 2018-03-27 Tx date 2018-03-23 |
$COM
Cardiome Pharma Corp. |
Hunter, William L.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,120,500
+450,000 vol $2.49 each |
1,533,000 | |
| Filed 2018-03-27 Tx date 2018-03-23 |
$COM
Cardiome Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$311,250
+125,000 vol $2.49 each |
442,700 | |
| Filed 2017-10-16 Tx date 2017-10-10 |
$COM
Cardiome Pharma Corp. |
Archibald, Jennifer
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,081.64
-17,164 vol $2.51 each |